Pulmonary hair embolism in monkeys

Insights

Daily injections in monkeys caused skin and hair emboli in lungs (7.6%) and injection site lesions (91%). Most lesions healed after treatment stopped, with no lasting pulmonary issues observed.

Area of Science:

  • Veterinary Pathology
  • Toxicology
  • Primate Research

Background:

  • Intravenous injections are common in preclinical studies.
  • Potential complications include embolism and local tissue reactions.

Purpose of the Study:

  • To evaluate the safety and potential adverse effects of daily intravenous injections in non-human primates.
  • To assess the incidence of pulmonary emboli and injection site reactions.

Main Methods:

  • 184 rhesus and cynomolgus monkeys received daily intravenous injections for 28 days.
  • Animals were monitored for pulmonary lesions and injection site reactions.
  • Histopathological examination was performed on relevant tissues.

Main Results:

  • Pulmonary emboli, containing skin or hair fragments, were found in 7.6% of the monkeys.
  • Injection site lesions, primarily bleeding and chronic periphlebitis, occurred in 91% of animals.
  • Skin or hair particles were rarely found around the injection veins (2.2%).

Conclusions:

  • Daily intravenous injections can lead to pulmonary embolism and local inflammatory responses in non-human primates.
  • The observed lesions showed a high degree of healing after treatment cessation.
  • These findings highlight the importance of aseptic techniques during injections in primate studies.

Related Concept Videos

Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...